Title: SARC031: A Phase 2 Trial of the MEK Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Combination with the mTOR Inhibitor Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors Status: Recruiting For more information about this trial, contact: AeRang Kim, M.D., Ph.D
If you are diagnosed with coeliac disease, your doctor will refer you to see a dietitian
Ethics declarations Ethics approval and consent to participate The current study was approved by the Research Ethics Committee of Isfahan University of Medical Sciences (ID: IR.MUI.RESEARCH.REC.1400.037, March 2021)
Raw, cold pressed organic
Magnesium is good for your heart, bones, nerves and muscles
Body composition changes after stopping GLP-1 receptor agonists: weight regain, fat regain, and lean mass recovery [17:45]